BM8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioMarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 52.86 EUR 1.89% Market Closed

Market Cap: €10B

B	BioMarin Pharmaceutical Inc SWB:BM8	US
A	AECOM SWB:E6Z	US
Z	Zoetis Inc SWB:ZOE	US
P	Ping An Insurance (Group) Co of China Ltd F:PZX	CN
	Wynn Resorts Ltd LSE:0QYK	US

Profitability Summary

BioMarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

78% > 80%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

18%

Operating Margin is Increasing

5% > 20%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Declining Net Margin

6% > 2%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.